Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumStamatia Karagianni, Alexis Moscoso Rial, Martijn van Essen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersStamatia Karagianni, Alexis Moscoso Rial, Martijn van Essen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanomaMartijn van Essen, Eric P Krenning, Peter P Kooij, et al.
Seminars in Nuclear Medicine|February 2, 2010
Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumorsDik J Kwekkeboom, Wouter W de Herder, Casper H J van Eijck, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 27, 2021
Incidental cardiac findings on somatostatin receptor PET/CT: What do they indicate and are they of clinical relevance?Emanuele Bobbio, Anna Dudás, Anders Bergström, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2008
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotateBart de Keizer, Maarten O van Aken, Richard A Feelders, et al.
Endocrine-Related Cancer|December 10, 2009
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumorsDik J Kwekkeboom, Boen L Kam, Martijn van Essen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2008
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survivalDik J Kwekkeboom, Wouter W de Herder, Boen L Kam, et al.
Hematology Reports|November 24, 2025
AI Improves Agreement and Reduces Time for Quantifying Metabolic Tumour Burden in Hodgkin LymphomaMay Sadik, Sally F Barrington, Johannes Ulén, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2026
Concordance Between [18F]Flortaucipir PET Visual Reads and CenTauR-Based QuantificationStamatia Karagianni, Alexis Moscoso, Sheelakumari Raghavan, et al.
Pageof 4